Wishful Thinking: The Surprisingly Sparse Evidence for a Relationship between Oxidative Stress and Cardiovascular Disease in Hemodialysis Patients

被引:11
作者
Bossola, Maurizio [1 ]
Tazza, Luigi [1 ]
机构
[1] Univ Cattolica Sacro Cuore, Hemodialysis Unit, Div Transplantat, Agostino Gemelli Univ Hosp, I-00168 Rome, Italy
关键词
CORONARY-ARTERY CALCIFICATION; INTIMA-MEDIA THICKNESS; STAGE RENAL-DISEASE; GLYCATION END-PRODUCTS; VASCULAR CALCIFICATION; SERUM MALONDIALDEHYDE; MORTALITY; ATHEROSCLEROSIS; EVENTS; RISK;
D O I
10.1111/sdi.12345
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The increased frequency of cardiovascular disease observed in hemodialysis patients is secondary to the combination of many traditional (age, male sex, hypertension, smoking, diabetes mellitus, and dyslipidemia) and novel and uremia-related (inflammation, uremic toxins, adipokine imbalance, coagulation disorders, protein-energy wasting, volume overload, endothelial dysfunction, hyperparathyroidism, and subclinical hypothyroidism) risk factors. Usually, in the latter group, oxidative stress is included. However, after decades of research, it remains essentially unknown if oxidative stress has a causative role in the development of cardiovascular disease in long-term hemodialysis patients because adequate longitudinal studies are lacking. Data deriving from cross-sectional studies suggest that biomarkers of oxidative stress are associated with cardiovascular disease prevalence. Conversely, conflicting and inconclusive results have been obtained on the association between oxidative stress and coronary artery calcification, atherosclerosis, and all-cause and cardiovascular disease-related outcome. It is desirable that further studies are conducted on this topic in the near future.
引用
收藏
页码:224 / 230
页数:7
相关论文
共 64 条
  • [1] A simple vascular calcification score predicts cardiovascular risk in haemodialysis patients
    Adragao, T
    Pires, A
    Lucas, C
    Birne, R
    Magalhaes, L
    Gonçalves, M
    Negrao, AP
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2004, 19 (06) : 1480 - 1488
  • [2] Oxidative DNA damage correlates with carotid artery atherosclerosis in hemodialysis patients
    Ari, Elif
    Kaya, Yuksel
    Demir, Halit
    Cebi, Aysegul
    Alp, Hamit Hakan
    Bakan, Ebubekir
    Odabasi, Dolunay
    Keskin, Siddik
    [J]. HEMODIALYSIS INTERNATIONAL, 2011, 15 (04) : 453 - 459
  • [3] Oxidised LDL/LDL-cholesterol ratio and coronary artery calcification in haemodialysis patients
    Asamiya, Y.
    Yajima, A.
    Tsuruta, Y.
    Otsubo, S.
    Nitta, K.
    [J]. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2013, 23 (07) : 619 - 627
  • [4] Coronary calcification in hemodialysis patients: The contribution of traditional and uremia-related risk factors
    Barreto, DV
    Barreto, FC
    Carvalho, AB
    Cuppari, L
    Cendoroglo, M
    Draibe, SA
    Moyses, RMA
    Neves, KR
    Jorgetti, V
    Blair, A
    Guiberteau, R
    Canziani, MEF
    [J]. KIDNEY INTERNATIONAL, 2005, 67 (04) : 1576 - 1582
  • [5] Homocysteine, C-reactive protein, lipid peroxidation and mortality in haemodialysis patients
    Bayés, B
    Pastor, MC
    Bonal, J
    Juncà, J
    Hernandez, JM
    Riutort, N
    Foraster, A
    Romero, R
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2003, 18 (01) : 106 - 112
  • [6] Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients
    Block, G. A.
    Raggi, P.
    Bellasi, A.
    Kooienga, L.
    Spiegel, D. M.
    [J]. KIDNEY INTERNATIONAL, 2007, 71 (05) : 438 - 441
  • [7] Serum malondialdehyde and prevalent cardiovascular disease in hemodialysis
    Boaz, M
    Matas, Z
    Biro, A
    Katzir, Z
    Green, M
    Fainaru, M
    Smetana, S
    [J]. KIDNEY INTERNATIONAL, 1999, 56 (03) : 1078 - 1083
  • [8] Baseline oxysterols and other markers of oxidative stress, inflammation and malnutrition in the vitamin E and intima media thickness progression in end-stage renal disease (VIPER) cohort
    Boaz, M
    Iuliano, L
    Himmelfarb, J
    Matas, Z
    Micheletta, F
    McMonagle, E
    Friedman, V
    Natoli, S
    Gvirtz, G
    Biro, A
    Smetana, S
    Sabo, G
    Gafter, U
    Weinstein, T
    [J]. NEPHRON CLINICAL PRACTICE, 2005, 100 (04): : C111 - C119
  • [9] Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial
    Boaz, M
    Smetana, S
    Weinstein, T
    Matas, Z
    Gafter, U
    Iaina, A
    Knecht, A
    Weissgarten, Y
    Brunner, D
    Fainaru, M
    Green, MS
    [J]. LANCET, 2000, 356 (9237) : 1213 - 1218
  • [10] Reactive oxygen metabolites (ROMs) are associated with cardiovascular disease in chronic hemodialysis patients
    Bossola, Maurizio
    Vulpio, Carlo
    Colacicco, Luigi
    Scribano, Donata
    Zuppi, Cecilia
    Tazza, Luigi
    [J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2012, 50 (08) : 1447 - 1453